DOV vs SUPN · P/E 27, rev $4.24B vs rev $426.8M
Dover Corporation (DOV) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the DOV and SUPN stock pages for the full models.
Not investment advice.